![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0197.png)
References
195
Rademacher, L., Salama, A., Grunder, G., & Spreckelmeyer, K. N. (2014). Differential patterns of nucleus accumbens
activation during anticipation of monetary and social reward in young and older adults. Soc Cogn Affect
Neurosci, 9(6), 825-831.
Ragozzino ME (2007) The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial
striatum to behavioral flexibility. Ann N Y Acad Sci 1121:355-375.
Ragozzino ME, Ragozzino KE, Mizumori SJ, Kesner RP (2002) Role of the dorsomedial striatum in behavioral
flexibility for response and visual cue discrimination learning. Behav Neurosci 116:105-115.
Ragozzino ME, Wilcox C, Raso M, Kesner RP (1999) Involvement of rodent prefrontal cortex subregions in strategy
switching. Behav Neurosci 113:32-41.
Ravizza SM, Moua KC, Long D, Carter CS (2010) The impact of context processing deficits on task-switching
performance in schizophrenia. Schizophrenia research 116:274-279.
Redgrave P, Prescott TJ, Gurney K (1999) The basal ganglia: a vertebrate solution to the selection problem?
Neuroscience 89:1009-1023.
Reeves S, Bench C, Howard R (2002) Ageing and the nigrostriatal dopaminergic system. Int J Geriatr Psychiatry
17:359-370.
Robbins TW (2000) Chemical neuromodulation of frontal-executive functions in humans and other animals.
Experimental brain research 133:130-138.
Robbins TW (2002) ADHD and addiction. Nat Med 8:24-25.
Robbins TW (2007) Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical
implications. Philosophical transactions of the Royal Society of London Series B, Biological sciences 362:917-932.
Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic
modulation. Annu Rev Neurosci 32:267-287.
Robbins TW, Everitt BJ (1992) Functions of dopamine in the dorsal and ventral striatum. seminars in The
Neurosciences 4:119-127.
Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol
6:228-236.
Robbins TW, Everitt BJ (2003) Motivation and reward. In: Fundamental neuroscience, 2 Edition (Squire LR, Bloom
F, McConnell S, Roberts J, Spitzer N, Zigmond M, eds), pp 1109-1126. London: Academic Press.
Robbins TW, Everitt BJ (2007) A role for mesencephalic dopamine in activation: commentary on Berridge (2006).
Psychopharmacology (Berl) 191:433-437.
Roberts, A. C., De Salvia, M. A., Wilkinson, L. S., Collins, P., Muir, J. L., Everitt, B. J., & Robbins, T. W. (1994).
6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the
Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci, 14(5 Pt 1), 2531-2544.
Rogers RD, Monsell S (1995) Costs of a predictable switch between simple cognitive tasks. J Exp Psychol Gen
124:207-231.
Rokem A, Landau AN, Prinzmetal W, Wallace DL, Silver MA, D’Esposito M (2012) Modulation of inhibition of
return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype. Cereb
Cortex 22:1133-1138.
Rowe G, Hirsh JB, Anderson AK (2007) Positive affect increases the breadth of attentional selection. Proc Natl Acad
Sci U S A 104:383-388.
Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E (2009) Methylphenidate normalises activation
and functional connectivity deficits in attention and motivation networks in medication-naive children with
ADHD during a rewarded continuous performance task. Neuropharmacology.
Rubia K, Halari R, Cubillo A, Smith AB, Mohammad AM, Brammer M, Taylor E (2011) Methylphenidate normalizes
fronto-striatal underactivation during interference inhibition in medication-naive boys with attention-deficit
hyperactivity disorder. Neuropsychopharmacology 36:1575-1586.